Leukocytosis is a condition defined by an abnormally high white blood cell (WBC) count in the blood, typically exceeding 11,000 cells per microliter. While often a natural response to infection or inflammation, it can also be a side effect of various medications. For clinicians, differentiating drug-induced leukocytosis from a more serious pathological cause like infection or leukemia is a critical diagnostic challenge. Understanding the specific medications and their mechanisms is essential for accurate interpretation of a patient's blood work.
Corticosteroids: A Common Culprit
Corticosteroids, such as prednisone and dexamethasone, are one of the most common causes of drug-induced leukocytosis. This is often a neutrophilic leukocytosis, meaning the increase is primarily due to neutrophils, a specific type of white blood cell. The mechanism involves several key actions:
- Demargination: Corticosteroids cause neutrophils that are typically 'parked' along the walls of blood vessels to detach and enter the main circulation.
- Delayed Migration: They inhibit the movement of neutrophils from the bloodstream into tissues, trapping them in circulation for longer periods.
- Increased Release: Steroids can stimulate the bone marrow to release more neutrophils into the blood.
- Delayed Apoptosis: They can prolong the life of existing neutrophils by delaying programmed cell death.
Studies show that the magnitude of leukocytosis is often dose-dependent, with higher doses causing a more significant increase. The WBC count typically peaks around 48 hours after administration and gradually declines thereafter.
Lithium's Role in Increasing Leukocytes
Lithium carbonate, a medication used to treat bipolar disorder and other psychiatric conditions, is also well-known for causing leukocytosis. In many patients, this effect is persistent throughout treatment. For some individuals, the increase is significant enough that lithium has been explored as a treatment for drug-induced leukopenia (low WBC count). Unlike corticosteroids, lithium's effect on WBCs is less understood but is known to involve stimulating the bone marrow to produce more leukocytes.
Therapeutic Colony-Stimulating Factors (G-CSFs)
Granulocyte-colony stimulating factors (G-CSFs) are a class of medications specifically designed to increase the number of white blood cells, particularly neutrophils. These are not a side effect, but rather the intended therapeutic purpose of the drug. Examples include filgrastim (brand names Neupogen, Zarxio, Nivestym) and its long-acting form, pegfilgrastim (Neulasta). G-CSFs work by stimulating the bone marrow to produce and release more neutrophils, a critical strategy for patients undergoing chemotherapy or those with severe neutropenia.
Other Medications Implicated in Leukocytosis
Several other medication classes have been reported to cause an increase in WBC counts, including:
- Beta-agonists: Drugs like albuterol can cause a temporary leukocytosis through demargination of white blood cells.
- Epinephrine: Similar to beta-agonists, epinephrine can cause a transient increase in WBC counts.
- Select Antibiotics and Anticonvulsants: Some reports implicate certain types of antibiotics and anticonvulsants, although the mechanisms are often less defined.
- Allopurinol: This medication, used for gout, can also cause an elevated WBC count.
Comparison: Drug-Induced vs. Pathological Leukocytosis
Determining the cause of leukocytosis involves considering the clinical context, lab results, and medication history. The following table highlights key differences between drug-induced and pathological leukocytosis:
Feature | Drug-Induced Leukocytosis (e.g., Corticosteroid) | Pathological Leukocytosis (e.g., Infection) |
---|---|---|
Onset | Occurs shortly after medication initiation, often peaking within 48 hours. | Can occur rapidly with acute infection or gradually with chronic conditions. |
WBC Differential | Typically neutrophilia with reduced lymphocytes, monocytes, and eosinophils. | Varies based on pathogen (e.g., neutrophilia for bacteria, lymphocytosis for viruses). |
Cell Morphology | Generally, cells appear mature and normal, lacking features like toxic granulation. | Often presents with immature cell forms ('shift to the left') or toxic granulation. |
Clinical Symptoms | Unaccompanied by typical infection symptoms like fever, chills, or worsening malaise. | Accompanied by other signs of infection or inflammation. |
Resolution | Resolves once the medication is tapered or discontinued. | Resolves as the underlying infection or inflammation is treated. |
Conclusion: The Importance of Context
Numerous medications can cause an increase in leukocytes, and distinguishing between a benign drug effect and a more serious condition is crucial. Understanding how and when medications like corticosteroids, lithium, and G-CSFs affect white blood cell counts is a vital part of clinical practice. Always provide your complete medication history to your healthcare provider, as this information is essential for interpreting laboratory results correctly. While a high WBC count can be a normal immune response, persistent and unexplained elevations warrant further medical investigation to rule out other underlying causes.
For more information on the various causes of leukocytosis, consult the StatPearls article on Leukocytosis.